ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

Rosen Law Firm is notifying Ardelyx, Inc. investors of a securities class action lawsuit with a November 16, 2026 lead plaintiff deadline. The lawsuit alleges that Ardelyx made materially false and misleading statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing information about payer access barriers, prior authorization requirements, and step edit requirements that hindered patient access and new-patient starts.